XML 65 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
The following table is a reconciliation of the Company’s business segments to the consolidated financial statements: 
In millions
Pharmacy Services
Segment(1)(2)
 
Retail Pharmacy
Segment(2)
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
2014:
 

 
 

 
 

 
 

 
 

Net revenues
$
88,440

 
$
67,798

 
$

 
$
(16,871
)
 
$
139,367

Gross profit
4,771

 
21,277

 

 
(681
)
 
25,367

Operating profit
3,514

 
6,762

 
(796
)
 
(681
)
 
8,799

Depreciation and amortization
630

 
1,205

 
96

 

 
1,931

Total assets
42,302

 
30,979

 
2,530

 
(1,559
)
 
74,252

Goodwill
21,234

 
6,908

 

 

 
28,142

Additions to property and equipment
308

 
1,745

 
83

 

 
2,136

2013:
 

 
 

 
 

 
 

 
 

Net revenues
$
76,208

 
$
65,618

 
$

 
$
(15,065
)
 
$
126,761

Gross profit
4,237

 
20,112

 

 
(566
)
 
23,783

Operating profit
3,086

 
6,268

 
(751
)
 
(566
)
 
8,037

Depreciation and amortization
560

 
1,217

 
93

 

 
1,870

Total assets
38,343

 
30,191

 
4,420

 
(1,428
)
 
71,526

Goodwill
19,658

 
6,884

 

 

 
26,542

Additions to property and equipment
313

 
1,610

 
61

 

 
1,984

2012:
 

 
 

 
 

 
 

 
 

Net revenues
$
73,444

 
$
63,641

 
$

 
$
(13,965
)
 
$
123,120

Gross profit
3,808

 
19,091

 

 
(411
)
 
22,488

Operating profit
2,679

 
5,636

 
(694
)
 
(411
)
 
7,210

Depreciation and amortization
517

 
1,153

 
83

 

 
1,753

Total assets
36,057

 
29,492

 
1,408

 
(736
)
 
66,221

Goodwill
19,646

 
6,749

 

 

 
26,395

Additions to property and equipment
422

 
1,555

 
53

 

 
2,030

 
(1)
Net revenues of the Pharmacy Services Segment include approximately $8.1 billion, $7.9 billion and $8.4 billion of Retail co-payments for the years ended December 31, 2014, 2013 and 2012, respectively.
(2)
Intersegment eliminations relate to two types of transactions: (i) Intersegment revenues that occur when Pharmacy Services Segment clients use Retail Pharmacy Segment stores to purchase covered products. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue on a standalone basis and (ii) Intersegment revenues, gross profit and operating profit that occur when Pharmacy Services Segment clients, through the Company’s intersegment activities (such as the Maintenance Choice® program), elect to pick up their maintenance prescriptions at Retail Pharmacy Segment stores instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail Pharmacy segments record the revenue, gross profit and operating profit on a standalone basis. The following amounts are eliminated in consolidation in connection with the item (ii) intersegment activity: net revenues of $4.9 billion, $4.3 billion and $3.4 billion for the years ended December 31, 2014, 2013 and 2012, respectively; and gross profit and operating profit of $681 million, $566 million and $411 million for the years ended December 31, 2014, 2013 and 2012, respectively.